Biofrontera BFRI
NASDAQ BFRI
$0.93 +0.04 (+4.49%)
At close: Nov 10, 2026 · 4:00 PM EST

Biofrontera (BFRI) Net Equity Issued and Repurchased (2022 - 2025)

Updated

Biofrontera's Net Equity Issued and Repurchased was $7.66 million in FY2024, up 70.0% from $4.51 million in FY2023.

Analysis

Biofrontera (BFRI) Net Equity Issued and Repurchased (2022 - 2025) Analysis & Trends

From FY2021 onward, Biofrontera has reported Net Equity Issued and Repurchased for 4 years.

  • Net Equity Issued and Repurchased shows a three-year compound annual growth rate of -20.1% (FY2021 to FY2024).
  • Annual Net Equity Issued and Repurchased has moved between $4.51 million (FY2023) and $15 million (FY2021) over five years.
  • Per Business Quant data, Net Equity Issued and Repurchased in earlier years was $4.51 million in FY2023 (-52.0%), $9.39 million in FY2022 (-37.4%) and $15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Biofrontera 13.21 Mn -7.66 Mn 9.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.35 Mn
Mar 31, 2024 7.66 Mn
Sep 30, 2022 4.63 Mn
API Access

Biofrontera Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BFRI&period=max&api_key=YOUR_API_KEY